| 1995 |
Thompson DD, Simmons HA, Pirie CM, Ke HZ. FDA guidelines and animal models for osteoporosis. Bone. October 1995;17(4)(suppl):S125-S133. |
20 |
20 |
| 2021 |
Morrell AE, Robinson ST, Ke HZ, Holdsworth G, Guo XE. Osteocyte mechanosensing following short-term and long-term treatment with sclerostin antibody. Bone. August 2021;149:115967. |
0 |
0 |
| 1992 |
Ke HZ, Jee WSS, Mori S, Li XJ, Kimmel DB. Effects of long-term daily administration of prostaglandin-E₂ on maintaining elevated proximal tibial metaphyseal cancellous bone mass in male rats. Calcif Tiss Int. March 1992;50(3):245-252. |
5 |
4 |
| 2005 |
Li J, Liu D, Ke HZ, Duncan RL, Turner CH. The P2X7 nucleotide receptor mediates skeletal mechanotransduction. J Biol Chem. December 30, 2005;280(52):42952-42959. |
31 |
23 |
| 2008 |
Li X, Ominsky MS, Niu Q, Sun N, Daugherty B, D'Agostin D, Kurahara C, Gao Y, Cao J, Gong J, Asuncion F, Barrero M, Warmington K, Dwyer D, Stolina M, Morony S, Sarosi I, Kostenuik PJ, Lacey DL, Simonet WS, Ke HZ, Paszty C. Targeted deletion of the sclerostin gene in mice results in increased bone formation and bone strength. J Bone Miner Res. June 2008;23(6):860-869. |
63 |
59 |
| 2009 |
Li X, Ominsky MS, Warmington KS, Morony S, Gong J, Cao J, Gao Y, Shalhoub V, Tipton B, Haldankar R, Chen Q, Winters A, Boone T, Geng Z, Niu Q-T, Ke HZ, Kostenuik PJ, Simonet WS, Lacey DL, Paszty C. Sclerostin antibody treatment increases bone formation, bone mass, and bone strength in a rat model of postmenopausal osteoporosis. J Bone Miner Res. April 2009;24(4):578-588. |
57 |
52 |
| 2013 |
Spatz JM, Ellman R, Cloutier AM, Louis L, van Vliet M, Suva LJ, Dwyer D, Stolina M, Ke HZ, Bouxsein ML. Sclerostin antibody inhibits skeletal deterioration due to reduced mechanical loading. J Bone Miner Res. April 2013;28(4):865-874. |
24 |
20 |
| 2014 |
Ominsky MS, Niu Q-T, Li C, Li X, Ke HZ. Tissue-level mechanisms responsible for the increase in bone formation and bone volume by sclerostin antibody. J Bone Miner Res. June 2014;29(6):1424-1430. |
24 |
22 |
| 2017 |
Kim SW, Lu Y, Williams EA, Lai F, Lee JY, Enishi T, Balani DH, Ominsky MS, Ke HZ, Kronenberg HM, Wein MN. Sclerostin antibody administration converts bone lining cells into active osteoblasts. J Bone Miner Res. May 2017;32(5):892-901. |
18 |
16 |